Q: I was bullish on this for some time because the Ontario Gov't paid them to develop expanded, locally produced lab products, including but not limited to COVID and other testing reagents and VTM.
My fear was that a cheap, rapid test would make their COVID line irrelevant, but variants may be just the thing to keep their more technical tests relevant long-term.
How would you now view their risk/return as I want to add to my small 1% position?
Q: Last question on this company dates back to 2017. It has had a nice ride up; but is currently taking an ugly and fast ride down. Down 15% for me in about 1 week alone. My “rules” say sell! Should I? Or can hanging in anticipation of a turnaround be justified?
What does the future look like for this company based on your analysis?